Wow, the hits just keep on coming. Related:
“A Republican lawmaker is demanding to know why the Biden administration appears to be limiting the ability of doctors to order early treatment medications for COVID-19 patients.
Rep. Chip Roy (R-Texas) on Monday sent a letter to Department of Health and Human Services Secretary Xavier Becerra inquiring about a recent change in HHS policy that limits orders and shipments of monoclonal antibody treatments to HHS-approved administration sites.”
https://www.theblaze.com/news/hhs-reviewing-orders-for-monoclonal-antibodies
that’s to be expected, tho. It’s probably a sign we’ve eaten thru the stockpile, and not enough being produced right now for it to be on-demand at any location in the US for all ages. Maybe Regeneron will have some mfg news soon.
From wiki (cause it was fast), as part of Operation Warp Speed, “Regeneron expected to produce 70,000–300,000 treatment doses....”
and in Jan, 2021, Regeneron “ specified that it currently had 50,000 doses and that it expected to reach a total of 300,000 doses “within the next few months.”